2-[<sup>18</sup>F]FDG PET in the Management of Radioiodine Refractory Differentiated Thyroid Cancer in the Era of Thyrosin-Kinases Inhibitors: A Real-Life Retrospective Study

2-[<sup>18</sup>F]FDG PET in the Management of Radioiodine Refractory Differentiated Thyroid Cancer in the Era of Thyrosin-Kinases Inhibitors: A Real-Life Retrospective Study

Purpose To evaluate the role of 2-[<sup>18</sup>F]FDGPET/CT in the follow-up of radioiodine refractory thyroid cancer (RR-TC). Methods Forty-six 2-[<sup>18</sup>F]FDGPET/CT scans from 14 RR-TC patients were considered. Thyroid function tests: thyroglobulin (Tg), levothyroxine...

Full description

Bibliographic Details
Main Authors: Stefano Gay, Stefano Raffa, Anna De’Luca di Pietralata, Matteo Bauckneht, Lara Vera, Alberto Miceli, Manuela Albertelli, Silvia Morbelli, Massimo Giusti, Diego Ferone
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Diagnostics
Subjects:
2-[<sup>18</sup>F]FDGPET/CT
radioiodine refractory thyroid cancer
prognosis
Online Access:https://www.mdpi.com/2075-4418/12/2/506

Internet

https://www.mdpi.com/2075-4418/12/2/506

Similar Items